Exelixis | Capital Ordinaire





Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Akebia Therapeutics USD 2K 0 2025-03
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bayer EUR 982.42M 0 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cytokinetics USD 122.12M 2.52M 2025-09
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
Exelixis USD 268.1M 2.03M 2025-09
Genmab DKK 10M 56M 2025-03
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
Merck USD 2.49B 15.79M 2025-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Takeda JPY 1.58B 2K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Xencor USD 71.34M 46K 2025-09


Exelixis Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.